Skip to content

Drug interactions

Encorafenib + Vortioxetine

Severity: Minor

Encorafenib and Vortioxetine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Encorafenib can both inhibit and induce CYP3A4, so its effect on vortioxetine exposure is unpredictable. Vortioxetine levels may rise, increasing adverse effects such as nausea, or fall, reducing antidepressant effect.

What this interaction means in plain words

Encorafenib and Vortioxetine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Encorafenib belongs to Oncology; Vortioxetine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Mixed CYP3A4 inhibition and induction by encorafenib alters the partial CYP3A4-mediated metabolism of vortioxetine; vortioxetine is mainly metabolized by CYP2D6, so the net effect is likely small.

What to do

Monitor for tolerability and for loss of antidepressant response when starting or stopping encorafenib. Adjust the vortioxetine dose according to clinical response.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Encorafenib and Vortioxetine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Encorafenib with Vortioxetine?

MediHelp rates the interaction as minor. Encorafenib and Vortioxetine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Encorafenib can both inhibit and induce CYP3A4, so its effect on vortioxetine exposure is unpredictable. Vortioxetine levels may rise, increasing adverse effects such as nausea, or fall, reducing antidepressant effect.

How serious is the interaction between Encorafenib and Vortioxetine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for tolerability and for loss of antidepressant response when starting or stopping encorafenib. Adjust the vortioxetine dose according to clinical response.

What other medicines interact with Vortioxetine?

MediHelp also lists interactions of Vortioxetine with, for example, Isocarboxazid, Linezolid, Methylene blue. The full list is on the Vortioxetine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in